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Prescribing by mental health nurses: Scripting the issues in the United 
KingdomThe UK Perspective 
 
Steve Hemingway and Valerie Mills 
Steve Hemingway, MA, PGDE, BA (Hons) V300 (Nurse prescriber)RMN, is a Senior 
Lecturer in Mental Health, Health and Human Sciences, University of Huddersfield, 
Huddersfield, Yorkshire, United Kingdom 
 
Purpose. To discuss the growth of mental health nurse (MHN) prescribing in the 
United Kingdom as an exemplar for readers to compare progress in their own 
countries and context.  
Structure. Provide historical overview and reasons why nurse prescribing has 
developed and, specifically, relate this to MHNs’ practice. Establish the requirement 
for MHNs to prescribe safely and competently in the United Kingdom. Compare the 
United Kingdom with other countries’ developments and specifically the United 
States.   
Conclusions/Practice Implications.  Finally, evidence has shown that MHNs with 
prescriptive authority are competent when prescribing as compared to psychiatrists. 
Despite organizational barriers and educational concerns MHN prescribing is 
becoming embedded in the healthcare context in the United Kingdom. 
Search terms: Mental health nursing, nurse prescribing, United Kingdom  
 
 
Prescribing by mental health nurses (MHNs) was first introduced in 2001 in the 
United Kingdom.  Since that time approximately 10,000 nurses have undertaken 
educational programmes that allow them to act as independent or supplementary 
prescribers; however, the current estimate is that only 1000 MHNs have completed  
programmes, representing less than 3% of the workforce in the United Kingdom ( 
Snowden 2008). In the United Kingdom, prescribing programmes are closely 
regulated and are required to include 27 days of theoretical input at undergraduate 
level 3 (equivalent to the final year level of a baccalaureate degree) with a minimum 
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of 12 days supervised practise by a medical practitioner (National Prescribing Centre, 
the National Institute for Mental Health in England, and the Department of Health 
[NPC], 2005). On successful completion of both elements, the MHN can potentially 
prescribe any drug from the British National Formulary (BNF).  
 The number of nurse prescribers has very recently increased exponentially 
after a relatively low level of uptake of programmes in the early 2000s.  Government 
support for national implementation in mental health was published (NPC, 2005). 
This was followed swiftly as one of the key roles identified in the recent Chief 
Nursing Officer’s (England) review for MHNs to truly make a difference to care 
delivery (Department of Health [DH] 2006a, 2007). There is now growing evidence 
of increased prescribing activity by MHNs (Grant, Page, & Maybury, 2006; 
Hemingway & Harris, 2006; Jones & Jones, 2007; Norman et al., 2007; Wix, 2007). 
Despite the momentum behind prescribing, some commentators continue to question 
the efficacy of this development.  These include doubts that MHNs in the United 
Kingdom are educated to a level that will underpin competent and safe prescribing, 
concerns that the programmes (27 theory and 12 days of clinical supervision 
placement) are insufficient to prepare a nurse prescriber, and the understanding that 
the relationship between numbers of nurse prescribers and improved service provision 
for the service user has yet to be established (NPC, 2005).   
This article will provide an overview of the brief history of nurse prescribing 
in the United Kingdom and discuss the issues driving its development.   Then issues 
associated with the law, safety, and competency will be explored. A comparison of 
MHN prescribing in the United Kingdom with the rest of the world, but specifically 
the United States, will be offered, followed by a discussion of the future direction of 
MHN prescribing in the United Kingdom. 
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MHNs and Their Role in Prescribing Psychotropic Medication 
MHNs in the United Kingdom have always played a major role in the delivery 
of physical treatments, but this has traditionally been under the direction of the 
medical superintendent (Nolan, 1993). Asylum attendants, the Victorian predecessors 
of MHNs, exercised considerable autonomy in determining which treatments to utilise 
when faced with severely disturbed patients. Although in many cases appropriate 
decisions about use of medical treatments may have been made by asylum nurses up 
to the 1960s, reports of the care of the mentally ill are littered with scandals 
concerning the abuse of patients and an emphasis on control rather than care. The 
emergence of treatments for symptoms of many of the major mental illnesses, such as 
depression, schizophrenia, bi-polar affective disorder, and anxiety, in the 1950s 
changed the face of mental health care in the United Kingdom and advanced the 
eminence of the psychiatrist (Rogers & Pilgrim, 2001), with the now professionally 
recognised and registered MHN administering these new treatments. This also offered 
the opportunity that those experiencing mental health problems could be seen by a 
doctor, diagnosed and prescribed medication that enabled them to remain at home and 
avoid becoming a long-term institutionalised hospital patient. Alongside advances in 
treatment, came the championing of community as a way for mental health care to be 
located in society rather than hidden away in the asylums (Rogers & Pilgrim). 
 Although it took a further 4 decades to develop the more comprehensive 
inpatient and community-based specialist services found today, the MHNs who 
emerged from the asylum system have, by necessity, had to adapt to primary care as 
the prime context of care. This led to the emergence of community psychiatric nurses 
(CPNs) who could work more autonomously with service users to manage their 
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problems in the home setting, liaising as appropriate with other service providers 
(e.g., social services, housing, etc.) in order to support care in the community (Nolan, 
1993).  
 Within these new roles, CPNs played a significant role in prescribing 
decisions, although frequently in the absence of specific training post-qualification, 
particularly about psychotropic medication. This was evident in primary-care liaison 
with general practitioners (GPs) and in discussions with junior doctors (Gournay & 
Gray, 2001; Ramcharan Hemingway, & Flowers, 2001). For example, Ramcharan et 
al. found CPNs were consulted by GPs in an advisory capacity on what psychotropic 
medication was appropriate to prescribe for the service user. This prescribing activity, 
known as defacto or proxy prescribing was unauthorised, with no legal endorsement. 
Given the shift to primary care as the chief location for mental health services and the 
availability of a mental health workforce in place, a rational and natural development 
was for the proxy role to be formalised. This state, coupled with a national shortage of 
psychiatrists, proved an economic alternative and one that offered greater prescribing 
choice and flexibility for people with mental illnesses (NPC, 2005). 
 The non-medical prescribing (NMP) initiative began in the United Kingdom 
with nurse, midwife, and health visiting prescribing.  Humphries and Green (2002) 
noted that as far back as 1980 the U.K. Royal College of Nursing was advocating  
registered nurses should be allowed to prescribe medicines.  However it was not until 
the publication of the Cumberlege Report in 1986 that it first achieved Government 
policy status (Department of Health & Social Security, 1986).  The conservative 
government of the time was keen to increase care in the community (DH, 1989a); 
Cumberlege, in preparation, was asked to investigate how the role and responsibilities 
of neighbourhood nurses, namely district nurses and health visitors, would need to 
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change to facilitate the shift to greater primary-care-led health care.  Cumberlege 
reported that neighbourhood nurses regularly and independently assessed patients for 
conditions related to their practice and subsequently made treatment decisions.  It was 
noted that to enact those clinical decisions, they needed to request prescriptions for 
their patients from GPs. The nurses often exercised de facto prescribing in the steer 
they gave to GPs, but the process resulted in much time wasting for the patients, GPs, 
and the district nurses/health visitors’ alike (Luker, Austin, Ferguson, & Smith, 1997).  
More significantly, Otway (2002) noted that these de-facto prescriptions were often 
rubber stamped by the GPs. This could compromise the safety of patients and 
undermine the accountability of the GPs involved, since prescribing decisions were 
undertaken by a medical practitioner distanced from the assessment and examination 
of the patient concerned and dependent on the capability of the nurse undertaking it.   
 Building on the recommendations of the Cumberlege report, the first Crown 
Report (DH, 1989b) proposed prescribing by district nurses and health visitors from a 
limited formulary, referred to as the Nurse Prescribers Formulary.  The belief was that 
implementation of the limited prescribing would have direct patient benefit (DH, 
1989a, Brew 1999).  
 In 1994, a pilot project undertaken on eight sites across the country allowed 
suitably prepared district nurses and health visitors to prescribe from a limited 
formulary.  The evaluation demonstrated that these limited prescribing rights 
improved services by facilitating more effective use of resources (Luker[Author: is 
this Luker et al , 1997( a)). Nevertheless worries remained about the possible cost of 
implementation, particularly as there was a (misplaced) belief that limited nurse 
prescribing would encourage wasteful dispensing of unused items.  Despite these 
concerns and following the successful implementation of limited nurse prescribing, 
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the Government supported the case made for prescribing to be within the scope of 
practice of all registered nurses (DH, 1999). This was the first opportunity for MHNs 
to prescribe, as prior to this the limited formulary was not seen as within their scope 
of practice. Further developments in support of widening the scope of nurse 
prescribing emanated from the National Health Service (NHS)Plan (DH, 2000), as it 
was seen to offer service improvement by reducing delays waiting for a doctor to 
prescribe for the service user and recognised the potential to draw on and build upon 
MHN’s expertise.  
 In 2001, nurse prescribing was extended, and this included MHNs (DH, 2001,  
2002).  This formulary allowed all first-level registered nurses who had undertaken an 
approved educational programme and supervised practise to prescribe all general sales 
list pharmacy medicines and a further 200 specified prescription-only medicines.  A 
year later, supplementary prescribing (similar to complementary prescribing in the 
United States) was introduced (DH, 2003).   Supplementary prescribing requires the 
production of a written clinical management plan (CMP) agreed between the 
independent prescriber (doctor), nurse, and service user.  However, the doctor must 
first confirm the assessment and diagnosis before then setting out the prescription, 
including types of drugs and extent to which they can be prescribed by the 
supplementary prescriber. CMPs are dependent upon the parameters defined by the 
individual doctor (and their confidence in the competence of the supplementary 
prescriber) and can limit the scope of the MHN or can be facilitative, thus allowing 
the nurse to prescribe any class of psychotropic drug (NPC, 2005).  
 More recently, the law has been extended, allowing nurses to qualify and 
practise as independent prescribers (similar to substitutive practice in the United 
States). Following approved training, nurses can now prescribe any licensed medicine, 
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including some controlled drugs, as long as they work within the limits of their 
knowledge and competence (DH, 2007).  Full independent nurses, including 
prescribing of all controlled drugs, is imminent.  This change will allow nurses 
working in the field of substance misuse to prescribe methadone, a Schedule 2 
controlled drug, once full-controlled drug prescribing is legalised.  This would offer a 
major role enhancement and facilitate more effective case management (Risk Review, 
2008). Table 1 summarises the milestones that have contributed to the development of 
nurse prescribing in the United Kingdom.  It is worth noting that non-medical 
prescribing in the United Kingdom is not just an extension of the scope of practice of 
nurses, midwives, and health visitors. Since 2002, pharmacists have been allowed to 
train as supplementary prescribers.  Physiotherapists, podiatrists, radiographers, and 
optometrists have, since 2005, also been included.  The extension to independent 
prescribing was offered to Pharmacists in 2006, and even more recently, in 2007, 
optometrists have been allowed to independently prescribe for conditions of the eye 
and surrounding tissue. 
 
The Development of Nurse Prescribing 
 
Nurse Prescribing: A Positive Development? 
Given that the health service is resource finite, there are political attractions in 
nurse prescribing, not least in relation to potential savings (DH, 1999; Gournay & 
Gray 2001; Jones, 2004). Evidence suggests that many people diagnosed with 
schizophrenia, depression, bi-polar affective disorder, and[dementia are not receiving 
appropriate medical treatment. The reasons are many but include the shortage of 
psychiatrists (Gournay & Gray), failure of GPs to diagnose and prescribe 
appropriately (Nolan, Haque, Badger, Dyke, & Khan, 2001), and volume of cases, 
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particularly from what has been described as a pandemic of depression (Bailey & 
Hemingway, 2006).  Alongside, service users report feeling disempowered during 
consultations with their doctors, particularly feeling that their non-medical needs are 
not given due consideration. The NPC (2005) suggested that non-medical prescribing 
undertaken by MHNs could: 
 
• Allow service users quicker access to medication 
• Provide services more efficiently and effectively 
• Increase service user choice, and 
• Make better use of nurses’ skills and knowledge. 
 
 
 Indeed early results suggest that appropriately trained MHNs have shown they 
can make a significant difference to both health- and social-care outcomes (Grant et 
al., 2007 Wix, 2007; Jones & Jones 2008) and improve the prescribing experience of 
service users.  
Extension of non-medical prescribing is not without criticism.  It has been 
argued that prescribing has been used by the current Government to challenge the 
power of the  medical profession[Author: Is “medicine” correct?] (McCartney, 
Tyrer, Brazier, & Prayle, 1999). Non-medical prescribing, in effect, eliminates the 
gate-keeping role traditionally exerted through doctors’ prescribing powers, thus 
removing their control. Others suggest that there is danger of dumbing down the 
underlying expertise inherent in medical prescribing by this role extension. James, 
Sheppardand Rafferty, (1999) offered a different perspective by suggesting that the 
development of nurse prescribing was part of a quest for professional aggrandisement, 
removing dependence on the medical profession for professional legitimacy. Indeed 
Jones  (2004) extends this by arguing that prescribing has become the territory of 
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gender divisions; he offered that prescribing was kept on the Government’s agenda by 
“female nursing” asserting itself alongside “male medicine.”  
 In contrast McCann and Baker (2002) locate the argument against prescribing 
in the care versus cure debate.  Suggesting that MHNs who adopt prescribing may 
place too great an emphasis on diagnostic activity and pharmacological cures, thus 
diminishing their attention on caring. Countering that position Bailey and Hemingway 
(2006) suggest prescribing by MHNs positively challenges nurses to work within a 
holistic framework, one where psychobiologic perspectives can be seen alongside 
psychosocial approaches. The skills and knowledge associated with the 
pathophysiology of illness is [Author: word OK as changed?  This sentence needs 
a verb.]an area that has become increasingly absent from the education and practise 
of MHNs for some time (Jordan, 2002[Author: please add to the reference list]; 
Nolan et al., 2001; Gournay & Gray, 2001; Bailey & Hemingway).  Cressey (2007) 
questions whether MHNs possess the requisite skills and knowledge necessary to 
deliver the prescribing services already available from doctors.  Others suggest the 
increased emphasis on psychopharmacological approaches emerged from the decade 
of the brain (1990s) and was a consequence of the increasing influence of 
pharmaceutical companies in health care (Cutliffe, 2002; Keen, 2006).  
 Despite these criticisms, non-medical prescribing is developing rapidly. In the 
United Kingdom, in the aftermath of the case involving Dr. Harold Shipman, a GP 
who abused his position to murder frail older people with controlled drugs, 
professional autonomy is increasingly under surveillance. Nurses will soon be able to 
independently prescribe controlled drugs in the United Kingdom; this represents a 
major professional development from nurse prescribing from the limited formulary in 
the 1990s to today. It also presents new challenges, temptations, and burden for 
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professional integrity.  The recent reviews of mental health nursing in England and 
Scotland, although encouraging of prescribing, envisage frameworks to facilitate and 
monitor its development and activities of practitioners (Snowden, 2007). 
 
Nurse Prescribing and the Law (See Table 2) 
 
The Medicines Act of 1968 remains the legislative framework for prescribing 
medicines in the United Kingdom. The Act restricts the prescribing of prescription 
only medicines to appropriate practitioners including nurses, originally doctors, 
dentists, and veterinariansThe Medicines Act was amended by The Medicinal 
Products: Prescription by Nurses Etc Act 1992 to allow nurses to prescribe from a 
limited formulary[Author: please provide references for all of these Acts in this 
paragraph in the reference list so readers will be able to find them.]. This was 
followed by amendments to the Pharmaceutical Services Regulations 1994 that 
allowed pharmacists to dispense prescriptions written by nurses. Extended nurse 
prescribing rights were enabled by the same statutory provision.  Supplementary 
Prescribing was enacted by The Health and Social Care Act (2001). 
 With the enactment of The Mental Capacity Act (2005) and [Author: correct 
as changed?] the changes to The Mental Health Act 2007 the complexity of consent 
came to the fore. For MHNs, extending their role to include prescribing brings another 
layer of complexity to capacity to consent. Further exploration of this important topic 
is beyond this paper, but Jones et al ..(b),Hemingway and Williams[Author: which 
one?  Jones, Bennett, Lucas, Miller, & Gray or Jones, Hemingway, & Williams?] 
(2007) and Dimond (2008) offer further discussion about this topic.  
The Authority to Prescribe 
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MHNs who successfully complete the required programme(s) of theory and 
practice can undertake two modes of prescribing. These are:   
• Independent prescribing, where any licensed medicine including some 
controlled drugs can be prescribed by a non-medical prescriber with 
the requisite knowledge and competence working within their scope 
of practice,  
• Supplementary prescribing, where the non-medical prescriber in 
partnership with the psychiatrist (independent prescriber) and service 
user are able to prescribe any medicine, including all controlled drugs 
and unclicensed medicines, that are listed in a clinical management 
plan (DH, 2007).  
 
The mode of prescribing the MHN adopts in practise is dependent on the context and 
service user presentation (Jones, M., Bennett, Lucas, Millar, & Gray, 2007; Wix, 
2007). Most MHNs (at the time of writing) are more likely to be acting as 
supplementary rather than independent prescribers[Author: sentence OK as 
changed?].  Some MHNs have indicated they would feel more comfortable working 
within the boundaries of a CMP[Author: citation?].  This allows the novice 
prescriber to establish their confidence under the supervision of a psychiatrist 
(Hemingway, 2004). In contrast to this, MHNs have identified where acting as an 
independent prescriber is more appropriate based on practice context and service user 
need (Wix; Bradley, Wain, & Nolan, 2008). 
Prescribing Competence 
Whether MHNs have the appropriate assessment, diagnosis, and consultation 
skills as well as adequate understanding of psychopharmacology needed to prescribe 
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psychotropic drugs has been much debated (Skingsley, Bradley, & Nolan, 2006; 
Bailey & Hemingway, 2006); Jones & Jones, 2006[Author: please add Jones & 
Jones, 2006 to the reference list]). Indeed much questioning of nurses’ capacity to 
prescribe safely has emerged, particularly from medical commentators (Avery & 
Pringle, 2005; Cressey, 2007). The adequacy of the preparation programmes for the 
Independent and Supplementary Nurse Prescribing course, with its 27 days of theory 
and 12 days of supervised practise, have received scrutiny.  The Nursing and 
Midwifery Council [NMC] (2006) stipulated the minimum academic level be an 
undergraduate level 3 for the course in contrast with the master’s prepared 
programmes in the United States (Bailey & Hemingway, 2006). This, however, may 
well have been a pragmatic decision given that many pre-registration nursing 
programmes in England remain at sub-degree level (diploma, advanced diploma) and 
many post-registration continuing professional development (CPD) [Author: 
courses? pProgrammes?] for nurses remain at bachelor’s degree level. This is, 
however, changing, and many higher education institutions (HEIs) have approved 
programmes at both bachelor’s and master’s levels. Interdisciplinary prescribing 
education has, in part, brought about this change.  Most HEIs offer non-medical 
prescribing students one programme irrespective of discipline. As the majority of 
eligible non-medical professions require graduate level entry for initial registration, 
master’s level CPD is the norm.  
 The unique nature of MH [Author: MHN?] prescribing has questioned the 
need for a specific MH [Author: MHN?] module (Wright & Jones 2007; Snowden 
2007). Further, some suggest that potential students should complete a mandatory 
module on medicines management and psychopharmacology as a pre-requisite to 
entry to prescribing programmes (Skingsley et al., 2006). The author believes that 
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placing additional uniform pre-requisites on MHNs is unnecessary but suggests 
emphasis on individual prior experience and baseline knowledge.  Key components to 
achieving competence are: 
 
• Pre-course confidence regarding knowledge of medication;  
 
• appropriate, supportive supervision by a medical practitioner, in the case of 
MHNs, a psychiatrist;  
• accessing medicines management and psychopharmacological education 
opportunities;  
• developing practise within a supportive and well-organised environment.  
 
These components are not unique to MHNs but incorporate lessons learned from 
other healthcare settings where more widespread adoption of prescribing has 
occurred. Changing patterns of service delivery in primary and secondary care 
settings has facilitated greater adoption of non-medical prescribing and, in particular, 
independent prescribing.  Mills (2008) offered an example of organisations that have 
sound clinical governance systems in place, an essential feature for successful 
implementation.   
 
The Context of Mental Health Nurse Prescribing 
In a review of 46 students exiting prescribing programmes in the north of 
England, Hemingway and Harris (2006) found that the students (all MHNs) were 
recruited from a range of settings (See Table 3). 
Jones et al.[Author: which one?  Jones, Bennett, Lucas, Miller, & Gray or 
Jones, Bennett, Lucas & Gray 2006Jones, Hemingway, & Williams?] (2007) 
confirms this picture in their mapping of the locations where nurses are issuing 
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prescriptions.  The highest levels of MHN prescribing activity seem to be taking place 
in older peoples’ services (Grant et al., 2007[Author: Please add Grant et al., 2007 
to the reference list (unless this is Grant et al. 2006, then please correct the 
date)]; Gray, Parr, & Brimblecombe, 2005; Murray, 2007).  There is also significant 
activity in adult services, albeit mostly in services provided in secondary care, 
community, and out-patient clinics (Snowden, 2007). Nevertheless, significant 
developments are emerging in adult mental health in-patient care (Jones M., Bennett, 
et al. 2007; Jones & Jones, 2008), forensic services, prisons, and primary care settings 
(NPC, 2005). Some activity also exists in child and adolescent services (Ryan, 2007). 
 
Implementation 
 
Despite the evidence that prescribing by MHNs is developing across a wide 
range of services, and positive news that MHN prescribing has evaluated safely 
(Norman et al., 2007), the reality in the United Kingdom is that its implementation by 
mental health service providers (NHS Trusts) has been patchy (Bradley et al., 2008). 
In 2004 just four NHS trusts employed 81% of the MHN prescribers who had 
completed their training (Murray, 2007; NPC, 2005). It would appear that employers 
that championed the implementation of MHN prescribing have identified tangible 
benefits (Bradley et al.; Jones & Jones, 2007, 2008; Jones M., Bennett, et al., 2007).  
However this picture does not reflect the United Kingdom as a whole where service 
improvement through the introduction of non-medical prescribing is best described as 
piecemeal and haphazard (Mazhindu & Brownshill, 2003[Author:  please add to the 
reference list]; NPC, 2005).   Too frequently, MHNs have undergone training to 
prescribe without the employing organisation having a governance framework in 
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place.  One study illustrates this in its finding that only 51% of MHNs trained were 
actually practising as prescribers (Gray et al., 2005). Mental health service providers 
appear to be more cautious and roll out slower than in acute and primary care settings 
(DH, 2005b; NPC, 2005). Despite this finding, the significance of prescribing by 
nurses in mental health has been signalled in both reviews of mental health nursing in 
England and Scotland (DH, 2006a; Snowden, 2007) as central to improving mental 
health service-user recovery.  
Recommendation 13 of Values to Action (DH, 2006 a[Author: a or b?]) set 
the agenda for organisations, stating:  
Service providers are to put in place arrangements to support the 
implementation of nurse prescribing, based on local need, taking into 
account the potential for service redesign and skill mix review, using 
both supplementary and independent prescribing arrangements (p. 13).  
This apparent slow development is unsurprising as the NHS deals with “boom bust” 
resourcing.  The adoption of prescribing across NHS organisations is often dependent 
on local championing. Unfortunately other initiatives and priorities such as patient 
safety and reduction of medication-related errors exert competing demands and 
concerns about risk.  In the micro world of local service planning between trusts 
(hospital and community organisations) and health commissioners, other issues 
inevitably become greater priorities.  
 
How does the UK nurse prescribing compare to the rest of the world? 
 
Nurses in several countries apart from the United Kingdom have the authority 
to prescribe medicines. These include Canada, Sweden, Australia, and the United 
States (Buchan & Calman, 2004[Author: please add to the reference list]). In New 
Zealand, the role of prescribing by nurses has been developing slowly for some time 
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(Hughes & Lockyer, 2004). The potential of nurse prescribing is also being debated in 
Ireland (Lockwood & Fealy, 2008), and plans are in place to push it forward in 
Holland (Van Ruth, Mistiaen, & Francke, 2008). The potential gain of nurses 
obtaining prescriptive authority has been reported in the United States (Cornwell & 
Chiverton, 1997) and Sweden (David & Brown, 1995), and are similar follow 
those[Author: What “are similar”?]to those set out in the United Kingdom by the 
NPC (2005; see  p. 7 of the article). Other contextual reasons, such as access to 
patients living in remote areas, shortage of doctors, and nurses working independently 
in these areas, has meant prescribing by nurses developed in Australia, Sweden, and 
Canada. In Africa, prescribing training for nurses is available (Meyer et al., 
2001[Author: please add to the reference list]) and is needed in low-income 
countries like Botswana and South Africa where the pandemic of AIDS could be 
helped by nurses’ abilities to prescribe medication (Miles, Seitio[Author: spelled 
“Seitio” in the reference list.  Which is correct?], & McGilvray, 2006).  
Prescribing by MHNs is being slowly implemented in Australia as part of 
MHNs’ advanced practice activities. Perhaps unsurprisingly a recent study (Elsom, 
Happell, Manias, 2007) found that Australian nurses have undertaken roles considered 
the legal domain of the medical profession, such as strongly influencing the 
prescribing of medicines, although the ultimate decision was made by the doctor. At 
the other extreme, nurse respondents in the study reported that they would make 
decisions in the absence of the doctor, clearly contravening the medical code. This 
defacto or proxy prescribing echoes the results of the Ramcharan et al. (2001) study in 
the United Kingdom where MHNs felt that the authority to prescribe would make 
legal even the rubber stamp interventions they undertook as part of their role.  
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Prescriptive authority for nurses is evidently developing across the globe. 
However the only context or evidence base to compare the developments in MHN 
prescribing in the United Kingdom is the U.S. context.  The picture in the United 
Kingdom is not dissimilar to that in the United States where the extension of 
advanced practice psychiatric nurse (APRNs) roles through nurse prescribing was not 
smooth.  Barriers were identified that have hindered widespread adoption of 
prescriptive authority (Kaas, Dahe, Dehn, & Frank, 1998; Campbell, Musil, & 
Zauszniewski, 1998; Talley & Richens, 2001). Studies suggest that lack of support 
from key professionals, especially psychiatrists, was a significant block. Psychiatrists 
reportedly either did not want to have the extra responsibility of supervising an MHN 
in their new prescribing role and the burden of vicarious responsibility (Kaas et al.; 
McCAallister[Author: spelled “McAllister” in the reference list.  Which is 
correct?], 1998), or they saw APRNs as potential economic rivals and a threat to their 
credibility (Glod & Manchester, 2000; Haber, Hamera, & Hillyer, 2003). 
Furthermore, it seems that there were some practice environments where bureaucratic 
barriers, such as excessive paperwork and a tortuous application process, hindered the 
progress of the MHN, as did a lack of recognition for the role and the added 
responsibility of nurse prescribing for APRNs (Glod & Manchester; Howard & 
Greiner, 1997; Kaas et al.). Other factors that appeared to hinder MHN prescribers 
feeling comfortable in their new role was their perceived knowledge deficits in 
prescribing, in addition to more generalised anxieties (Hales 2002; Howard & 
Greiner; Kaas et al.).   
 Further examination of the U.S. literature shows many similarities with the 
United Kingdom.  Barriers such as lack of support and restrictive work environments 
(Hemingway, 20056[Author: is this Hemingway, 2004 or 2005? Or Hemingway & 
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Harris, 2006? Or a new citation that needs to be added to the reference list?]; 
NPC, 2005) as well as anxieties about knowledge and abilities to undertake 
prescribing are described in the literature (Hemingway 2004, 20056[Author: Same as 
above]; Jones et al. a, 2007[Author: Jones, Hemingway of Jones, Bennett?]). 
Resistance voiced by physicians in the United States to APRNs practising with 
prescriptive authority has not been echoed in the United Kingdom in mental health. 
There has been acceptance of widening prescribing to MHNs, and some psychiatrists 
have welcomed the change (Jones et al., 2007a [Author: Jones, Hemingway of 
Jones, Bennett?]; Hemingway, 2008). The potential economic impact of APRN 
prescribing on doctors in the United States is not mirrored in the United Kingdom 
with its model of socialised health care. This may have influenced the acceptance of 
MHN prescribing by U.K. psychiatrists. 
What is positive about the U.S. context is that research studies have shown 
that the prescribing APRNs are as competent as psychiatrists in prescribing 
medication and also spend more quality time with the patient (Feldman, Bachman, 
Cuffel, Friesen, & McCabe, 2003; Fisher & Vaughan-Cole, 2003; Jacobs, 2005).  This 
mirrors the Norman et al. (20078[Author: Should this be 2007 or is it a new 
citation that needs to be added to the reference list?]) study in the United Kingdom 
that had similar findings regarding the competency of MHNs prescribing compared to 
psychiatrists. More studies like these are needed to provide robust evidence for 
service providers to plan for expanding MHN prescribing as well as service users to 
gain confidence in the change of prescribing service. 
 Inevitably change takes time, and after a slow start and resistance to MHN 
prescribing, it is gaining momentum as the impact on workload and care delivery has 
become apparent (DH, 2007).  As MHNs have adopted some of the routine activities 
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of prescribing, psychiatrists have more opportunity to concentrate on complex and 
demanding cases, in keeping with the Government vision (DH 2005a; DH 2006b). 
This two-tier prescribing could be seen as a form of dumbing down care provision, as 
forecast by McCartney et al. (1999). This has not been evident in evaluation to date 
that shows service users have responded to the greater inclusivity inherent in MHN 
prescribing (Grant et al., 2007[Author: 2006 or a new citation that needs to be 
added to the reference list?]; Jones & Jones 2008; Wix, 2007). The challenge 
incumbent on MHNs is that they remain committed to prescribing and use their 
powers to empower service users to effectively self-manage their prescribed 
medication, individualised to their wishes and lifestyle (Hales, 2002; Jones & Jones, 
2007; NPC, 2005). 
Mental Health Nurse Prescribing in the future 
The introduction of independent prescribing by MHNs throws up challenges 
for future educational provision. Independent prescribing can be seen as advanced 
practice.  Autonomous practice, including assessment, diagnosis, requesting tests and 
retests, demands sound knowledge and decision-making skills. How effectively HEIs 
facilitate the development of MHNs’ skills and knowledge to fulfil advanced practice 
roles is not yet fully evaluated. As graduate entry to nursing programmes [Author: 
OK as changed?]becomes the norm in the United Kingdom, the inevitable 
consequence is that prescribing education will be delivered at the master’s level, 
similar to advanced practice courses undertaken by APRNs in the United States 
(Bailey & Hemingway, 2006).   
 
Conclusion 
 The widespread adoption of MHN prescribing has spread and is impacting on 
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service users across the lifespan, from adolescence to older people, from inpatient to 
community and primary care (Hemingway & Harris, 2006). Critical debate around 
adoption of new roles continues to provide healthy challenges for MHNs to 
demonstrate their prescribing effectiveness, safety, effect on service improvement, 
and service user satisfaction (Bailey & Hemingway; Keen, 2006; Snowden, 2007). 
The national evaluation of MHN supplementary prescribing in the United Kingdom 
by Norman et al. (2007) displayed no significant difference in health- and social-care 
outcomes or the costs of prescribing. This study examined data from a sample of 90 
service users, suffering from depression or schizophrenia, whose medication was 
managed by an MHN supplementary prescriber or by an independent medical 
prescriber for a period of at least 6 months.  The research team also established that 
there were no significant differences in the safety of prescribing between the two 
groups using National Institute of Clinical Excellence (NICE) audit instrumentation 
(Norman et al.). They did report that the quality of documentation was generally poor, 
with a substantial amount of information relevant to safe prescribing practice absent 
from the records of patients in both groups (Norman et al.). Thus there can be cautious 
optimism. 
   Nevertheless, what is paramount is the need for careful planning and 
implementation of MHN prescribing. This needs to be undertaken on the basis of 
service need, organisational readiness, and availability of adequate resources. The 
benefits of role change of the MHN to incorporate prescribing also requires full 
consideration, particularly does the individual nurse understand the demanding 
requirement of education programmes, ongoing maintenance of competency, and 
burden of the additional responsibility that comes with greater autonomy. Prescribing 
is a powerful tool to support recovery but nurses adopting this role need to be 
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competent, confident, and above all aware that it is only one part of the therapeutic 
toolkit available to underpin their interventions with service users. 
I would like to acknowledge the contributions of Annie Topping Professor of Human 
and Health Sciences  and Val Ely Course Leader Non Medical Prescribing at the 
University of Huddersfield toward the development of this article. 
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